ELAVIL SUMMARY
ELAVIL (amitriptyline hydrochloride) is an antidepressant drug of the tricyclic type. ELAVIL is an antidepressant with sedative effects. Its mechanism of action in man is not known. It is not a monoamine oxidase inhibitor and it does not act primarily by stimulation of the central nervous system.
For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than are other depressive states.
|
|
NEWS HIGHLIGHTSMedia Articles Related to Elavil (Amitriptyline)
Brain Inflammation Tied to Depression, Suicidal Thoughts Source: Medscape Pathology & Lab Medicine Headlines [2017.09.29] Animal and postmortem studies point to a link between neuroinflammation and depression and suicidality. This study used PET scans to corroborate these findings in living human beings. Medscape Medical News
Sleep Deprivation a Rapid, Effective Depression Treatment Source: Medscape Psychiatry & Mental Health Headlines [2017.09.27] Sleep deprivation therapy may offer a rapid and effective treatment for depression, but results are short-lived. The question now is how to sustain benefit. Medscape Medical News
Postpartum Depression Likely to Recur With Future Pregnancies Source: MedicineNet Depression Specialty [2017.09.27] Title: Postpartum Depression Likely to Recur With Future Pregnancies Category: Health News Created: 9/26/2017 12:00:00 AM Last Editorial Review: 9/27/2017 12:00:00 AM
Cancer Patients May Have Undiagnosed Depression Source: MedicineNet Depression Specialty [2017.09.25] Title: Cancer Patients May Have Undiagnosed Depression Category: Health News Created: 9/25/2017 12:00:00 AM Last Editorial Review: 9/25/2017 12:00:00 AM
Asthma Drug Tied to Nightmares, Depression Source: MedicineNet Allergy Specialty [2017.09.22] Title: Asthma Drug Tied to Nightmares, Depression Category: Health News Created: 9/21/2017 12:00:00 AM Last Editorial Review: 9/22/2017 12:00:00 AM
Published Studies Related to Elavil (Amitriptyline)
Effect of minocycline on lumbar radicular neuropathic pain: a randomized,
placebo-controlled, double-blind clinical trial with amitriptyline as a
comparator. [2015] the treatment of neuropathic pain... CONCLUSIONS: Although both groups differed from placebo, their effect size was
Effect of Minocycline on Lumbar Radicular Neuropathic Pain: A Randomized,
Placebo-controlled, Double-blind Clinical Trial with Amitriptyline as a
Comparator. [2014] the treatment of neuropathic pain... CONCLUSIONS:: Although both groups differed from placebo, their effect size was
A phase III randomized, placebo-controlled study of topical amitriptyline and
ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of
Rochester CCOP study of 462 cancer survivors. [2014] efficacy of 2% ketamine plus 4% amitriptyline (KA) cream for reducing CIPN... CONCLUSIONS: This study suggests that KA cream does not decrease CIPN symptoms in
Electrocardiograms changes in children with functional gastrointestinal disorders
on low dose amitriptyline. [2014] children... CONCLUSION: The study findings suggest that once patients with functional
A meta-analysis of the therapeutic effects of amitriptyline for treating
irritable bowel syndrome. [2013] controlled trials... CONCLUSION: It was thus concluded that amitriptyline exhibits a clinically and
Clinical Trials Related to Elavil (Amitriptyline)
Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines [Enrolling by invitation]
This study will compare a local anesthetic technique that has been used to treat subjects
suffering from transformed migraines (chronic migraines) versus medical management with
traditional antidepressant Amitriptyline / Elavil.
Subjects will be randomized into one of two treatment groups to compare the safety and
efficacy of the therapies. Subjects will recieve either sphenopalatine ganglion nerve block
with 5% lidocaine gel into the nasopharynx or medical management with traditional
antidepressants, Elavil, to produce a reduction in the frequency and severity of the
headache.
We propose that there will be a difference in the outcomes when comparing the two methods of
treating transformed migraines and that one research arm will result in more patient
satisfaction and greater efficacy in the treatment of subjects
Study to Evaluate the Effect Single and Multiple Oral Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Amitriptyline and Nortriptyline in Healthy Male and Female Subjects [Completed]
The objective of the study was evaluate that there is no clinically relevant interaction
between amitriptyline (or its metabolite nortriptyline) and BIRT 2584 XX (or its metabolite
BI 610100) when BIRT 2584 XX is administered as a tablet formulation to near steady state in
an estimated high therapeutic dose. Pharmacokinetics (PK) of amitriptyline and nortriptyline
were measured before dosing of BIRT 2584 XX, after the first dose of BIRT 2584 XX, and after
repeated doses of BIRT 2584 XX near steady state
Low Doses Amitriptyline & Chronic Neck Pain [Completed]
The objective of this prospective randomized and controlled study is to evaluate the
efficacy and safety of low dose of amitriptyline (5 mg) in the management of chronic neck
pain.
Genetic Determinants of Amitriptyline Efficiency for Pain Treatment [Recruiting]
Low dose tricyclic antidepressant drugs are routinely administered co-analgesics in pain
medicine. Amitriptyline is largely considered as a gold standard. Amitriptyline underlies
cytochrome CYP2D6 and CYP2D19 metabolism. CYP2D6 is highly polymorphic; numerous genetic
variants result in 4 major classes characterizing enzymatic activity: poor metabolizers,
intermediate metabolizers, extensive metabolizers and ultrarapid metabolizers. It is not
known to which extent metabolizer classes determine pain outcomes or side-effects. As only
one in three pain patients is considered to be a responder to amitriptyline's co-analgesic
effect, prediction of treatment efficacy with a fast and easy to perform bedside test may
contribute to the patients quality of life. The aim of this study is to determine the
influence of cytochrome variants on experimental pain, drug related side-effects and finally
identification of active metabolites.
Genetic Determinants of Amitriptyline Efficiency for Pain Treatment - Part II [Recruiting]
Low dose tricyclic antidepressant drugs are routinely administered co-analgesics in pain
medicine. Amitriptyline is largely considered as a gold standard. Amitriptyline underlies
cytochrome CYP2D6 and CYP2D19 metabolism. CYP2D6 is highly polymorphic; numerous genetic
variants result in 4 major classes characterizing enzymatic activity: poor metabolizers,
intermediate metabolizers, extensive metabolizers and ultrarapid metabolizers. It is not
known to which extent metabolizer classes determine pain outcomes or side-effects. As only
one in three pain patients is considered to be a responder to amitriptyline's co-analgesic
effect, prediction of treatment efficacy with a fast and easy to perform bedside test may
contribute to the patients quality of life. The aim of this study is to determine the
influence of cytochrome variants on experimental pain, drug related side-effects and finally
identification of active metabolites.
Reports of Suspected Elavil (Amitriptyline) Side Effects
Drug Ineffective (14),
Drug Hypersensitivity (14),
Weight Increased (13),
Disturbance in Attention (13),
Pain (11),
Agitation (10),
Rash (10),
Fatigue (9),
Depression (9),
Toxicity TO Various Agents (9), more >>
|
PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 23 ratings/reviews, Elavil has an overall score of 7.52. The effectiveness score is 8.43 and the side effect score is 7.22. The scores are on ten point scale: 10 - best, 1 - worst. Below are selected reviews: the highest, the median and the lowest rated.
| Elavil review by 56 year old female patient | | Rating |
Overall rating: | |           |
Effectiveness: | | Considerably Effective |
Side effects: | | No Side Effects | | Treatment Info |
Condition / reason: | | Depression |
Dosage & duration: | | 25 mg. taken daily for the period of 12 years |
Other conditions: | | Sleep problems |
Other drugs taken: | | Erythrom. | | Reported Results |
Benefits: | | Although this drug was originally prescribed for depression, it helped with sleeplessness. Therefore, I have continued to take it for that alone. While I still on occasion have problems falling asleep, I find I can combine it with Melatonin or Valerian. In 12 years, I haven't had to increase the elavil dosage. |
Side effects: | | None. |
Comments: | | One a day, taken about an hour before bedtime. |
|
| Elavil review by 51 year old female patient | | Rating |
Overall rating: | |           |
Effectiveness: | | Considerably Effective |
Side effects: | | Mild Side Effects | | Treatment Info |
Condition / reason: | | sleep |
Dosage & duration: | | 35mg taken once a day for the period of 22years |
Other conditions: | | anxiety, shy, but overal healthy |
Other drugs taken: | | larozepam took for 5-6 years, discontinued | | Reported Results |
Benefits: | | helps me fall asleep and stay asleep |
Side effects: | | difficult to get up, tiredness in the morning, light sensitivity, constipation |
Comments: | | i have been take amitriptyline for the last 22 years, without too serious side effects. i never miss a dose- if by some reason i dont have it - i will never be able to fall asleep at all. I started on 10mg but now i am taking 35mg, it helps. |
|
| Elavil review by 61 year old female patient | | Rating |
Overall rating: | |           |
Effectiveness: | | Marginally Effective |
Side effects: | | Severe Side Effects | | Treatment Info |
Condition / reason: | | insomnia |
Dosage & duration: | | 150 mg taken once for the period of once |
Other conditions: | | sarcoidosis |
Other drugs taken: | | lisinopril, theophylline, cartia, premarin | | Reported Results |
Benefits: | | Highly effective for sleeping. |
Side effects: | | Slept for 3 days. Very disoriented and groggy! |
Comments: | | not exactly what I had in mind. I wake up during the night at 2 or 3 or 4 am
and am unable to go back to sleep, I wanted the ability to sleep through the night. But I did not want to sleep for 3 days!
I think maybe the initial dose was too high. I only took one tablet and never took another one. |
|
|
Page last updated: 2017-09-29
|